Clinical Trial Update: Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial sponsored by Northwestern University is evaluating atorvastatin for reducing colorectal cancer risk in longstanding ulcerative colitis. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Ulcerative Colitis

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Northwestern University | Conditions: Colorectal Carcinoma, Ulcerative Colitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING